Cargando…
Proposal of the French HIV Society on the CD4 threshold below which patients living with HIV who wish to be vaccinated against Monkeypox should receive a 3-dose regimen
Autores principales: | Pugliese, P., Arvieux, C., Huleux, T., Pialoux, G., Vignier, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528228/ https://www.ncbi.nlm.nih.gov/pubmed/36115536 http://dx.doi.org/10.1016/j.idnow.2022.09.013 |
Ejemplares similares
-
Wish list: which biomarker studies in HAM/TSP should be funded by the God of all trial funds?
por: Yamano, Yoshihisa
Publicado: (2014) -
High syphilis prevalence and incidence in people living with HIV and Preexposure Prophylaxis users: A retrospective review in the French Dat’AIDS cohort
por: Lemmet, Thomas, et al.
Publicado: (2022) -
Loss of long-term non-progressor and HIV controller status over time in the French Hospital Database on HIV - ANRS CO4
por: Grabar, Sophie, et al.
Publicado: (2017) -
Monkeypox Vaccine Hesitancy in French Men Having Sex with Men with PrEP or Living with HIV in France
por: Zucman, David, et al.
Publicado: (2022) -
Kaposi sarcoma among people living with HIV in the French DAT’AIDS cohort between 2010 and 2015
por: Poizot‐Martin, I., et al.
Publicado: (2020)